Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
Titel:
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
Auteur:
Haratani, K. Hayashi, H. Tanaka, T. Kaneda, H. Togashi, Y. Sakai, K. Hayashi, K. Tomida, S. Chiba, Y. Yonesaka, K. Nonagase, Y. Takahama, T. Tanizaki, J. Tanaka, K. Yoshida, T. Tanimura, K. Takeda, M. Yoshioka, H. Ishida, T. Mitsudomi, T. Nishio, K. Nakagawa, K.